TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effects of Upper Extremity Aerobic Exercise Training on Functional Exercise Capacity in Patients With Pulmonary Arterial Hypertension
Brief Summary: Decreased exercise capacity, peripheral muscle strength and quality of life and increased dyspnea and fatigue perception is prevalent in patients with pulmonary arterial hypertension. It was demonstrated exercise training has beneficial effects in patients with pulmonary arterial hypertension. However, no study investigated the effects of upper extremity aerobic exercise training, therefore effects of upper extremity aerobic exercise training on outcomes in patients with pulmonary arterial hypertension.


Options:
A: Arm Label: exercise training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: exercise training | Arm Label: Control group without exercise training; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: exercise training; Assigned to Arm(s): exercise training group
B: Arm Label: Exercise and Respiratory Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise and Respiratory Training | Intervention Type: BEHAVIORAL; Name: Exercise and Respiratory Training; Assigned to Arm(s): Exercise and Respiratory Training
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Physical training | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: No training | Intervention Type: BEHAVIORAL; Name: Physical training; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: No training; Assigned to Arm(s): 2
D: Arm Label: Training Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Upper extremity aerobic exercise training | Arm Label: Control Group; Type: SHAM_COMPARATOR; Interventions: Other: Alternative upper extremity exercises | Intervention Type: OTHER; Name: Upper extremity aerobic exercise training; Assigned to Arm(s): Training Group | Intervention Type: OTHER; Name: Alternative upper extremity exercises; Assigned to Arm(s): Control Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Placebo-controlled Study of the Use of Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
Brief Summary: This is a randomized, double-blind, placebo-controlled study of oral cromolyn sodium when made into a viscous preparation for the treatment of eosinophilic esophagitis.


Options:
A: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: budesonide | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: budesonide | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: budesonide | Intervention Type: DRUG; Name: budesonide; Assigned to Arm(s): 2, 3, 4 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 1
B: Arm Label: Low dose budesonide tablet; Type: EXPERIMENTAL; Interventions: Drug: low dose budesonide tablet | Arm Label: High dose budesonide tablet; Type: EXPERIMENTAL; Interventions: Drug: high dose budesonide tablet | Arm Label: High dose budesonide suspension; Type: EXPERIMENTAL; Interventions: Drug: high dose budesonide suspension | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: low dose budesonide tablet; Assigned to Arm(s): Low dose budesonide tablet | Intervention Type: DRUG; Name: high dose budesonide tablet; Assigned to Arm(s): High dose budesonide tablet | Intervention Type: DRUG; Name: high dose budesonide suspension; Assigned to Arm(s): High dose budesonide suspension | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Oral cromolyn; Type: EXPERIMENTAL; Interventions: Drug: oral cromolyn sodium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: oral cromolyn sodium; Assigned to Arm(s): Oral cromolyn | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Part A: Dupilumab or Placebo; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Arm Label: Part B: Dupilumab or Placebo; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab, Drug: Placebo | Arm Label: Part C: Dupilumab; Type: EXPERIMENTAL; Interventions: Drug: Dupilumab | Intervention Type: DRUG; Name: Dupilumab; Assigned to Arm(s): Part A: Dupilumab or Placebo, Part B: Dupilumab or Placebo, Part C: Dupilumab | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Part A: Dupilumab or Placebo, Part B: Dupilumab or Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Exercise to Prevent Depression and Anxiety in Older Hispanics
Brief Summary: The study is a randomized pilot trial of a health promotion intervention in the prevention of anxiety and depression in older Hispanics.


Options:
A: Arm Label: PLAN (intervention); Type: EXPERIMENTAL; Interventions: Behavioral: PLAN | Arm Label: Standard of care (control); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard of Care | Intervention Type: BEHAVIORAL; Name: PLAN; Assigned to Arm(s): PLAN (intervention) | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Standard of care (control)
B: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Educational Intervention, Behavioral: Placebo | Intervention Type: BEHAVIORAL; Name: Educational Intervention; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Placebo; Assigned to Arm(s): Control, Intervention
C: Arm Label: Health Promotion; Type: EXPERIMENTAL; Interventions: Behavioral: Happy Older Latinos are Active | Arm Label: Psychoeducation; Type: ACTIVE_COMPARATOR; Interventions: Other: Fotonovela | Intervention Type: BEHAVIORAL; Name: Happy Older Latinos are Active; Assigned to Arm(s): Health Promotion | Intervention Type: OTHER; Name: Fotonovela; Assigned to Arm(s): Psychoeducation
D: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Decision aid and navigation | Intervention Type: BEHAVIORAL; Name: Decision aid and navigation; Assigned to Arm(s): Intervention group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double Blind Community-based Randomized Trial of Amoxicillin Versus Placebo for Fast Breathing Pneumonia in Children Aged 2-59 Months in Karachi, Pakistan
Brief Summary: The relative benefits and risks of antibiotic therapy in WHO defined fast breathing pneumonia in pre-school children in resource limited settings are controversial both at an individual and public health level. Most infections are viral or self-limiting and non-selective drug treatment has contributed to the global epidemic of antibiotic resistance. There is no high quality trial evidence in managing children with fast breathing in community settings and the WHO itself has called for evidence on which to update guidance. The investigators proposed non inferiority trial comparing standard antibiotic treatment with placebo in poor urban slum settings in South Asia to address this deficit.


Options:
A: Arm Label: 3 days amoxicillin + 2 days placebo; Type: EXPERIMENTAL; Interventions: Drug: Amoxicillin, Drug: Placebo | Arm Label: 5 days amoxicillin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): 3 days amoxicillin + 2 days placebo, 5 days amoxicillin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3 days amoxicillin + 2 days placebo
B: Arm Label: Experimental; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Amoxicillin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Experimental | Intervention Type: DRUG; Name: Amoxicillin; Assigned to Arm(s): Control
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Motavizumab; Type: ACTIVE_COMPARATOR; Interventions: Biological: Motavizumab | Intervention Type: BIOLOGICAL; Name: Motavizumab; Assigned to Arm(s): Motavizumab | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Amoxycillin; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Using Mass Media to Promote Physical Activity in African American Women
Brief Summary: The purpose of this study is to evaluate the feasibility of a social media and text-message-delivered, Social Cognitive Theory-based, culturally relevant intervention designed to promote physical activity among African American women. An 8-week, 2-arm randomized trial will be implemented. Arm 1 will receive a culturally-relevant, technology-based physical activity intervention delivered via Facebook and text messages. Arm 2 (Comparison Group) will receive a standard print-based physical activity promotion materials consisting of high quality physical activity promotion brochures produced by the American Heart Association.


Options:
A: Arm Label: Lifestyle Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle Counseling | Arm Label: No Lifestyle Counseling; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle Counseling; Assigned to Arm(s): Lifestyle Counseling
B: Arm Label: Facebook and Text Message; Type: EXPERIMENTAL; Interventions: Behavioral: Facebook and text Message | Arm Label: Standard Print-based Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard Print-based Intervention | Intervention Type: BEHAVIORAL; Name: Facebook and text Message; Assigned to Arm(s): Facebook and Text Message | Intervention Type: BEHAVIORAL; Name: Standard Print-based Intervention; Assigned to Arm(s): Standard Print-based Intervention
C: Arm Label: PA intervention and Maintenance plus; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance plus | Arm Label: PA intervention and Maintenance regular; Type: EXPERIMENTAL; Interventions: Behavioral: Mobile phone based physical activity intervention with maintenance regular | Arm Label: Pedometer; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control (pedometer only) | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance plus; Assigned to Arm(s): PA intervention and Maintenance plus | Intervention Type: BEHAVIORAL; Name: Mobile phone based physical activity intervention with maintenance regular; Assigned to Arm(s): PA intervention and Maintenance regular | Intervention Type: BEHAVIORAL; Name: Control (pedometer only); Assigned to Arm(s): Pedometer
D: Arm Label: 10,000 step/day recommendation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 10,000 step/day recommendation | Arm Label: Adaptive recommendation; Type: EXPERIMENTAL; Interventions: Behavioral: Adaptive step recommendation | Intervention Type: BEHAVIORAL; Name: Adaptive step recommendation; Assigned to Arm(s): Adaptive recommendation | Intervention Type: BEHAVIORAL; Name: 10,000 step/day recommendation; Assigned to Arm(s): 10,000 step/day recommendation

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: My Team of Care (MyTOC) Trial: a Pilot Randomized Controlled Trial of an Online Communication Tool (Loop) for Collaborative Care in Complex Patients
Brief Summary: This project will pilot and test a new online communication tool, Loop, developed within a research framework with participatory and user-centred design. This pilot trial focuses on advanced cancer as an example of complex care. Cancer care involves many healthcare providers, spanning hospital to home. There is no organized way for them to communicate. Loop is a practical tool for ongoing collaboration in the patient's actual team of care that engages patients. The study will answer the questions: does Loop improve communication efficiency, engage patients and family physicians, and show early benefits in quality and health care costs?


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Communication, Behavioral: Systematic Pain Assessment and Treatment, Behavioral: Medication Review, Behavioral: Occupational therapy, Behavioral: Safety | Intervention Type: BEHAVIORAL; Name: Communication; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Systematic Pain Assessment and Treatment; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Medication Review; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Occupational therapy; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Safety; Assigned to Arm(s): Intervention
B: Arm Label: Goc Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: goals of care | Arm Label: usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: goals of care; Assigned to Arm(s): Goc Intervention
C: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: Loop | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Loop; Assigned to Arm(s): Intervention Group
D: Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Arm Label: Verbal Information and Discussion; Type: EXPERIMENTAL; Interventions: Other: Verbal Information and Discussion | Intervention Type: OTHER; Name: Verbal Information and Discussion; Assigned to Arm(s): Verbal Information and Discussion | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: My Team of Care (MyTOC) Trial: a Pilot Randomized Controlled Trial of an Online Communication Tool (Loop) for Collaborative Care in Complex Patients
Brief Summary: This project will pilot and test a new online communication tool, Loop, developed within a research framework with participatory and user-centred design. This pilot trial focuses on advanced cancer as an example of complex care. Cancer care involves many healthcare providers, spanning hospital to home. There is no organized way for them to communicate. Loop is a practical tool for ongoing collaboration in the patient's actual team of care that engages patients. The study will answer the questions: does Loop improve communication efficiency, engage patients and family physicians, and show early benefits in quality and health care costs?


Options:
A: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Device: Tablet: Samsung Galaxy Tab A | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Tablet: Samsung Galaxy Tab A; Assigned to Arm(s): Intervention
B: Arm Label: Electronic Symptom Survey; Type: EXPERIMENTAL; Interventions: Other: Electronic symptom survey | Arm Label: Blinded Electronic Symptom Survey; Type: ACTIVE_COMPARATOR; Interventions: Other: Blinded Electronic Symptom Survey | Intervention Type: OTHER; Name: Electronic symptom survey; Assigned to Arm(s): Electronic Symptom Survey | Intervention Type: OTHER; Name: Blinded Electronic Symptom Survey; Assigned to Arm(s): Blinded Electronic Symptom Survey
C: Arm Label: Tool + Self-management Support Program; Type: EXPERIMENTAL; Interventions: Device: Tool, Behavioral: Self-management Support Program | Arm Label: Self- management Support Program; Type: EXPERIMENTAL; Interventions: Behavioral: Self-management Support Program | Arm Label: Care as usual; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Tool; Assigned to Arm(s): Tool + Self-management Support Program | Intervention Type: BEHAVIORAL; Name: Self-management Support Program; Assigned to Arm(s): Self- management Support Program, Tool + Self-management Support Program
D: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Other: Loop | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Loop; Assigned to Arm(s): Intervention Group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 Attached to TCRζ and 4-1BB Signaling Domains in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell Therapy
Brief Summary: This is a pilot study to evaluate humanized CD19 redirected autologous T cells (or huCART19 cells) in patients with relapsed or refractory CD19+ leukemia and lymphoma that was previously treated with cell therapy. This study is targeting pediatric patients aged 1-24 years with CD19+ B cell malignancies with no available curative treatment options (such as autologous or allogeneic stem cell transplantation) who have a limited prognosis with currently available therapies and were previously treated with a B cell directed engineered cell therapy product.


Options:
A: Arm Label: Axicabtagene Ciloleucel Treatment; Type: EXPERIMENTAL; Interventions: Biological: Axicabtagene Ciloleucel, Drug: Cyclophosphamide, Drug: Fludarabine | Arm Label: Standard of Care Therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: Platinum-containing salvage chemotherapy (eg, R-ICE) followed by high dose therapy (eg, BEAM) and autologous stem cell transplant in responders. | Intervention Type: BIOLOGICAL; Name: Axicabtagene Ciloleucel; Assigned to Arm(s): Axicabtagene Ciloleucel Treatment | Intervention Type: DRUG; Name: Platinum-containing salvage chemotherapy (eg, R-ICE) followed by high dose therapy (eg, BEAM) and autologous stem cell transplant in responders.; Assigned to Arm(s): Standard of Care Therapy | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Axicabtagene Ciloleucel Treatment | Intervention Type: DRUG; Name: Fludarabine; Assigned to Arm(s): Axicabtagene Ciloleucel Treatment
B: Arm Label: 1A/T cell Arm (closed); Type: EXPERIMENTAL; Interventions: Procedure: Allogeneic stem cell transplant, Biological: Anti-CD19-chimeric-antigen-receptor-transduced T cells | Arm Label: 1B/T memory stem cell arm; Type: EXPERIMENTAL; Interventions: Procedure: Allogeneic stem cell transplant, Biological: Anti-CD19-chimeric-antigen-receptor-transduced T cells | Arm Label: 2/Donor arm; Type: OTHER; Interventions: Procedure: Leukapheresis | Intervention Type: PROCEDURE; Name: Allogeneic stem cell transplant; Assigned to Arm(s): 1A/T cell Arm (closed), 1B/T memory stem cell arm | Intervention Type: BIOLOGICAL; Name: Anti-CD19-chimeric-antigen-receptor-transduced T cells; Assigned to Arm(s): 1A/T cell Arm (closed), 1B/T memory stem cell arm | Intervention Type: PROCEDURE; Name: Leukapheresis; Assigned to Arm(s): 2/Donor arm
C: Arm Label: huCART19; Type: EXPERIMENTAL; Interventions: Biological: huCART19 | Intervention Type: BIOLOGICAL; Name: huCART19; Assigned to Arm(s): huCART19
D: Arm Label: Human CD19 targeted T Cells Injection; Type: EXPERIMENTAL; Interventions: Drug: Human CD19 targeted T Cells Injection | Intervention Type: DRUG; Name: Human CD19 targeted T Cells Injection; Assigned to Arm(s): Human CD19 targeted T Cells Injection

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multilevel Intervention to Increase Physical Activity and Improve Healthy Eating Among Young Children (Ages 3-5) Attending Early Childcare Centres: the Healthy Start Study
Brief Summary: Childhood obesity is one of the greatest challenges facing public health and recent evidence shows it begins in preschool aged children. It has been suggested that interventions be carried out to improve physical activity and healthy eating behaviour among young children. This study aims to fully evaluate Healthy Start, a multilevel physical activity and healthy eating intervention for preschool aged children. It is hypothesized that the Healthy Start intervention will improve both eating and physical activity behaviors of children attending early childcare centers because of its influence on multiple factors.


Options:
A: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Start | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Healthy Start; Assigned to Arm(s): Intervention arm
B: Arm Label: HENRY; Type: EXPERIMENTAL; Interventions: Behavioral: HENRY | Arm Label: Waiting list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: HENRY; Assigned to Arm(s): HENRY
C: Arm Label: Application use arm; Type: EXPERIMENTAL; Interventions: Behavioral: Intervention arm | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Intervention arm; Assigned to Arm(s): Application use arm
D: Intervention Type: BEHAVIORAL; Name: attitude change; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: adiposity prevention program; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multilevel Intervention to Increase Physical Activity and Improve Healthy Eating Among Young Children (Ages 3-5) Attending Early Childcare Centres: the Healthy Start Study
Brief Summary: Childhood obesity is one of the greatest challenges facing public health and recent evidence shows it begins in preschool aged children. It has been suggested that interventions be carried out to improve physical activity and healthy eating behaviour among young children. This study aims to fully evaluate Healthy Start, a multilevel physical activity and healthy eating intervention for preschool aged children. It is hypothesized that the Healthy Start intervention will improve both eating and physical activity behaviors of children attending early childcare centers because of its influence on multiple factors.


Options:
A: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Other: Childhood Obesity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Childhood Obesity; Assigned to Arm(s): Treatment
B: Intervention Type: BEHAVIORAL; Name: Targeted parental instruction for positive lifestyle change with follow-up calls.; Assigned to Arm(s): N/A
C: Arm Label: Standard HVP Curriculum; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard HVP Curriculum | Arm Label: Obesity Prevention; Type: EXPERIMENTAL; Interventions: Behavioral: Standard HVP Curriculum, Behavioral: Obesity Prevention | Intervention Type: BEHAVIORAL; Name: Standard HVP Curriculum; Assigned to Arm(s): Obesity Prevention, Standard HVP Curriculum | Intervention Type: BEHAVIORAL; Name: Obesity Prevention; Assigned to Arm(s): Obesity Prevention
D: Arm Label: Intervention arm; Type: EXPERIMENTAL; Interventions: Behavioral: Healthy Start | Arm Label: Control arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Healthy Start; Assigned to Arm(s): Intervention arm

Answer: D